203 related articles for article (PubMed ID: 27232383)
1. Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.
Li A; Makar RS; Hurwitz S; Uhl L; Kaufman RM; Stowell CP; Dzik WS; Bendapudi PK
Transfusion; 2016 Aug; 56(8):2069-77. PubMed ID: 27232383
[TBL] [Abstract][Full Text] [Related]
2. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
[TBL] [Abstract][Full Text] [Related]
6. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
[TBL] [Abstract][Full Text] [Related]
7. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
[TBL] [Abstract][Full Text] [Related]
8. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA
J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
[TBL] [Abstract][Full Text] [Related]
12. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD; McGinnis E; Smith TW
Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
[TBL] [Abstract][Full Text] [Related]
13. Successful plasma exchange in a 34-year-old woman with diabetic ketoacidosis and a thrombotic microangiopathy.
Hermelin D; Blackall D
J Clin Apher; 2020 Jan; 35(1):62-65. PubMed ID: 31652001
[TBL] [Abstract][Full Text] [Related]
14. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
17. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience.
Li XM; Mo XY; Huang GQ; Zhang FJ
Am J Emerg Med; 2021 Aug; 46():556-559. PubMed ID: 33214018
[TBL] [Abstract][Full Text] [Related]
18. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange.
Bentley MJ; Lehman CM; Blaylock RC; Wilson AR; Rodgers GM
Transfusion; 2010 Aug; 50(8):1654-64. PubMed ID: 20412532
[TBL] [Abstract][Full Text] [Related]
19. Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study.
Akpinar S; Tekgunduz E; Esen R; Yilmaz M; Karakus V; Vural F; Gediz F; Aydogdu I; Kaynar L; Goker H; Kelkitli E; Ayyildiz O; Demirkan F
Transfus Apher Sci; 2022 Feb; 61(1):103365. PubMed ID: 35120823
[TBL] [Abstract][Full Text] [Related]
20. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT; Cheves T; Sweeney JD
Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
